Holen Sie sich die Stockscreener-App
40.24
2.50%
-1.03
Handel nachbörslich:
40.18
-0.06
-0.15%
Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten
Viking Therapeutics Shares Fall 2.5% on $230M Volume (Rank 425th) as Pipeline Optimism Balances Sector Setbacks - AInvest
Why Is Viking Therapeutics Stock Gaining Wednesday?Viking Therapeutics (NASDAQ:VKTX) - Benzinga
The 3 Things That Matter for Viking Therapeutics Now - Yahoo Finance
IBD Rating Upgrades: Viking Therapeutics Shows Improved Price Strength - Investor's Business Daily
How does Viking Therapeutics Inc. correlate with NasdaqBreakout Return Surge Ideas - thegnnews.com
If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today - The Globe and Mail
Viking Therapeutics Concludes Broad Manufacturing Agreement With CordenPharma To Support Commercialization of VK2735 - Insider Monkey
Viking Therapeutics Inc. Builds Base for Possible ReboundCommunity Entry Consensus Trade Ideas Shared - beatles.ru
2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts - AOL.com
Viking Therapeutics Surges 6.55% on High-Volume Momentum Ranking 373rd as Liquidity-Driven Strategy Yields 166.71% Return - AInvest
Viking Therapeutics Stock Climbs on Promising Drug Results - TipRanks
Viking Therapeutics' VK2735 maintains competitive edge despite disappointing Eli Lilly data. - AInvest
Viking Therapeutics' VK2735 Shows Promising Phase 1 Results, Justifying Buy Rating - AInvest
Viking Therapeutics Surges 11.54% to 408th in Volume Amid Eli Lilly's Setback - AInvest
Viking Therapeutics call volume above normal and directionally bullish - TipRanks
Why Viking Therapeutics Stock is Climbing - TipRanks
Promising Phase 1 Results for Viking Therapeutics’ VK2735 Justify Buy Rating - TipRanks
Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors - Benzinga
Eli Lilly’s obesity drug data lifts Viking Therapeutics stock By Investing.com - Investing.com Canada
Viking Therapeutics Soars 11.39% on Acquisition Hopes, Obesity Drug Progress - AInvest
Three Stocks Showing Strong Buy Signals - AInvest
Is It Time to Buy Biotech Stocks? - The Motley Fool
Unlocking Viking Therapeutics' Potential with Upcoming Clinical Data - AInvest
Viking Therapeutics, Inc. (VKTX) Nears Obesity Drug Breakthrough with Phase 3 VK2735 Trial - MSN
Viking Therapeutics (VKTX) Is Considered a Good Investment by Brokers: Is That True? - MSN
This Biotech Stock Could Soar on Upcoming Clinical Data - AOL.com
Two Biotech Stocks with High Upside Potential: Viking Therapeutics and Recursion Pharmaceuticals - AInvest
What is the risk reward ratio of investing in Viking Therapeutics Inc. stockUnmatched market gains - Jammu Links News
VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales - The Globe and Mail
What institutional investors are buying Viking Therapeutics Inc. stockNavigate the market with precision tools - Jammu Links News
2 Beaten-Down Stocks With Incredible Upside Potential - Yahoo Finance
When is Viking Therapeutics Inc. stock expected to show significant growthIdentify safe investments with exceptional yields - Jammu Links News
What is the dividend policy of Viking Therapeutics Inc. stockExplosive earnings growth - Jammu Links News
What makes Viking Therapeutics Inc. stock price move sharplyGet professional advice for portfolio optimization - Jammu Links News
Is it the right time to buy Viking Therapeutics Inc. stockBuild a portfolio that stands the test of time - Jammu Links News
Is Viking Therapeutics Inc. stock overvalued or undervaluedFree Stock Selection - Jammu Links News
What are analysts’ price targets for Viking Therapeutics Inc. in the next 12 monthsMarket-beating returns - Jammu Links News
Is Viking Therapeutics the Next Big Biotech Bet? - AOL.com
Viking Therapeutics: A Promising Buy with Strategic Opportunities in Obesity Treatment and Direct-to-Consumer Market - TipRanks
Better Growth Buy: Eli Lilly vs. Viking Therapeutics - AOL.com
Viking Bets Big On Obesity And NASH With Dual-Agonist Pipeline - Finimize
Axsome Therapeutics and Viking Therapeutics: Biotech Stocks to WatchNews and Statistics - IndexBox
Wall Street Predicts Axsome Therapeutics and Viking Therapeutics Stocks to Soar 74% to 159% - AInvest
Why Viking Therapeutics Inc. stock attracts strong analyst attentionValue Investing Picks With Stability Outlined - metal.it
Sentiment Turns Positive on Viking Therapeutics Inc. — Reversal AheadMarket Entry and Exit Point Tips From Traders - metal.it
How does Viking Therapeutics Inc. compare to its industry peersDynamic investment growth - Jammu Links News
Raymond James Financial Issues Pessimistic Forecast for Viking Therapeutics (NASDAQ:VKTX) Stock Price - MarketBeat
Why is Viking Therapeutics Inc. stock attracting strong analyst attentionTriple returns potential - Jammu Links News
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):